BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 17664422)

  • 1. Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation.
    Wu CH; van Riggelen J; Yetil A; Fan AC; Bachireddy P; Felsher DW
    Proc Natl Acad Sci U S A; 2007 Aug; 104(32):13028-33. PubMed ID: 17664422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia.
    Yetil A; Anchang B; Gouw AM; Adam SJ; Zabuawala T; Parameswaran R; van Riggelen J; Plevritis S; Felsher DW
    Oncotarget; 2015 Feb; 6(6):3563-77. PubMed ID: 25784651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch.
    Giuriato S; Ryeom S; Fan AC; Bachireddy P; Lynch RC; Rioth MJ; van Riggelen J; Kopelman AM; Passegué E; Tang F; Folkman J; Felsher DW
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16266-71. PubMed ID: 17056717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras.
    Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A
    Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC synergizes with activated BRAFV600E in mouse lung tumor development by suppressing senescence.
    Tabor V; Bocci M; Alikhani N; Kuiper R; Larsson LG
    Cancer Res; 2014 Aug; 74(16):4222-9. PubMed ID: 24934810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of p21WAF1 cooperates with c-myc in bypassing Ras-induced senescence and enhances oncogenic cooperation.
    Carnero A; Beach DH
    Oncogene; 2004 Aug; 23(35):6006-11. PubMed ID: 15195145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogene-induced senescence as an initial barrier in lymphoma development.
    Braig M; Lee S; Loddenkemper C; Rudolph C; Peters AH; Schlegelberger B; Stein H; Dörken B; Jenuwein T; Schmitt CA
    Nature; 2005 Aug; 436(7051):660-5. PubMed ID: 16079837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence.
    Reimann M; Lee S; Loddenkemper C; Dörr JR; Tabor V; Aichele P; Stein H; Dörken B; Jenuwein T; Schmitt CA
    Cancer Cell; 2010 Mar; 17(3):262-72. PubMed ID: 20227040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
    Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
    Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tipping the balance: Cdk2 enables Myc to suppress senescence.
    Hydbring P; Larsson LG
    Cancer Res; 2010 Sep; 70(17):6687-91. PubMed ID: 20713526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short telomeres limit tumor progression in vivo by inducing senescence.
    Feldser DM; Greider CW
    Cancer Cell; 2007 May; 11(5):461-9. PubMed ID: 17433785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activity.
    Wu S; Hultquist A; Hydbring P; Cetinkaya C; Oberg F; Larsson LG
    Exp Cell Res; 2009 Nov; 315(18):3099-111. PubMed ID: 19766114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Myc/macrophage tango: oncogene-induced senescence, Myc style.
    Lee S; Schmitt CA; Reimann M
    Semin Cancer Biol; 2011 Dec; 21(6):377-84. PubMed ID: 22019769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYC Inactivation Elicits Oncogene Addiction through Both Tumor Cell-Intrinsic and Host-Dependent Mechanisms.
    Felsher DW
    Genes Cancer; 2010 Jun; 1(6):597-604. PubMed ID: 21037952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi.
    Bandyopadhyay D; Curry JL; Lin Q; Richards HW; Chen D; Hornsby PJ; Timchenko NA; Medrano EE
    Aging Cell; 2007 Aug; 6(4):577-91. PubMed ID: 17578512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods to study MYC-regulated cellular senescence.
    Tabor V; Bocci M; Larsson LG
    Methods Mol Biol; 2013; 1012():99-116. PubMed ID: 24006061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief inactivation of c-Myc is not sufficient for sustained regression of c-Myc-induced tumours of pancreatic islets and skin epidermis.
    Pelengaris S; Abouna S; Cheung L; Ifandi V; Zervou S; Khan M
    BMC Biol; 2004 Dec; 2():26. PubMed ID: 15613240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for synergistic interactions between ras, myc and a mutant form of p53 in cellular transformation and tumor dissemination.
    Taylor WR; Egan SE; Mowat M; Greenberg AH; Wright JA
    Oncogene; 1992 Jul; 7(7):1383-90. PubMed ID: 1620551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone modifications contribute to cellular replicative and hydrogen peroxide-induced premature senescence in human embryonic lung fibroblasts.
    Zhang W; Hu D; Ji W; Yang L; Yang J; Yuan J; Xuan A; Zou F; Zhuang Z
    Free Radic Res; 2014 May; 48(5):550-9. PubMed ID: 24528089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species.
    Ray S; Atkuri KR; Deb-Basu D; Adler AS; Chang HY; Herzenberg LA; Felsher DW
    Cancer Res; 2006 Jul; 66(13):6598-605. PubMed ID: 16818632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.